United States· US:0143-9867_b7be42f0-5b59-4a5a-a667-dfa81ff08b2a
Butorphanol Tartrate
A butorphanol product containing butorphanol tartrate, registered in United States by Hikma Pharmaceuticals USA Inc.. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Butorphanol is registered in 2 of 19 countries.
Countries holding a registration under ATC N02AF01 (butorphanol), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 1 of them publish a price we can compare per daily dose
Butorphanol · ATC N02AF01
2 / 19 countries
- Canada
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BUTORPHANOL TARTRATE
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Country
- United States (US)
- ATC code
- N02AF01
- ATC class
- Butorphanol
- Defined daily dose
- 12 mg, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1101439867101 mL in 1 VIAL, SINGLE-DOSE (0143-9867-10)
- ndc110143-9867-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
203 interactions on record for butorphanol.
Graded by severity as the source publishes them — 51 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Butorphanol · interactions on record
203 records
- 51 severe
- 113 moderate
- 39 info
Most severe, free to view
- ClotrimazoleA01AB18severe
- AprepitantA04AD12severe
- AlvimopanA06AH02severe
- OpiumA07DA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Butorphanol in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d39356b5-a5bc-45a3-bd13-2649f44e836b GET /v1/drugs/d39356b5-a5bc-45a3-bd13-2649f44e836b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAMUSCULAR; INTRAVENOUS",
"source": "ndc",
"strength": "2",
"substance": "BUTORPHANOL TARTRATE",
"productndc": "0143-9867",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": "CIV",
"strength_unit": "mg/mL",
"application_number": "ANDA078400",
"marketing_category": "ANDA"
}See everything about butorphanol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.